Uttam Yashwant Patil
Fortuna: 62 143 $ al 31/08/2026
Fortuna: 62 143 $ al 31/08/2026
Uttam Yashwant Patil currently works at AiBtl BioPharma, Inc., as Co-Chief Executive Officer from 2025, ABVC BioPharma, Inc., as Chief Executive & Financial Officer from 2023, Biokey, Inc., as Chief Operating & Scientific Officer from 2023, and Rgene Corp., as Manager-Research & Development from 2023.
Dr. Patil received his doctorate degree from National Tsing-Hua University and undergraduate degree and graduate degree from the University of Pune.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0,27 % | 27/02/2026 | 72.428 ( 0,27 % ) | 62 143 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ABVC BIOPHARMA, INC. | Director Ejecutivo | 23/06/2023 |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Director de Operaciones | 01/05/2023 |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Director Técnico/Científico/I+D | 01/05/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
National Tsing-Hua University
National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.